Ezh2tm1.1Nesh
Targeted Allele Detail
|
Symbol: |
Ezh2tm1.1Nesh |
Name: |
enhancer of zeste 2 polycomb repressive complex 2 subunit; targeted mutation 1.1, Norman E Sharpless |
MGI ID: |
MGI:6393578 |
Synonyms: |
Ezh2Y641F |
Gene: |
Ezh2 Location: Chr6:47507073-47572275 bp, - strand Genetic Position: Chr6, 22.92 cM, cytoband B
|
Alliance: |
Ezh2tm1.1Nesh page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:239472
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
C57BL/6 x 129
|
|
Allele Type: |
|
Targeted (Conditional ready, Humanized sequence) |
Mutations: |
|
Insertion, Single point mutation
|
|
|
Mutation details: A minigene containing a loxP site, exons 16-20, a STOP transcriptional/translational termination sequence, FRT-flanked neomycin resistance gene, a second loxP site, a mutated exon 16 containing a tyrosine to phenylalanine substitution at amino acid 641 (p.Y641F) in exon 16, and exons 17-20 replaced exons 16-20. Flp-mediated recombination removed the neomycin selection cassette. This allele expresses the wild-type transcript due to the STOP sequence. The Y641F allele is equivalent to the most common EZH2 missense allele, Y646F, in human cancers. Cre-mediated recombination can be used to remove the STOP sequence and express the mutation.
(J:239472)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
|
Original: |
J:239472 Souroullas GP, et al., An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nat Med. 2016 Jun;22(6):632-40 |
All: |
2 reference(s) |
|